An ever-shifting sales landscape calls for a nimble, responsive sales approach – one often problematic for the behemoth infrastructures of many large pharmaceutical organizations and the experience level of emerging biotechnology firms. As a result, commercial services partners offer a stronger than ever value proposition to the industry.